555 related articles for article (PubMed ID: 20192683)
1. Management of antibiotic resistance in the intensive care unit setting.
Petrosillo N; Capone A; Di Bella S; Taglietti F
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
[TBL] [Abstract][Full Text] [Related]
4. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
[TBL] [Abstract][Full Text] [Related]
5. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
Nikodemski T
Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
[TBL] [Abstract][Full Text] [Related]
6. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
Wei HJ; Liu LL; Xiaoli LY; Wang YP; Huang D; Pian HY; Zhu YC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
[TBL] [Abstract][Full Text] [Related]
7. [Distribution of pathogen and resistance of nosocomial infections in the intensive care units].
Dai CM; Zhou JD; Wu Y; Qi Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):277-80. PubMed ID: 16706133
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
[TBL] [Abstract][Full Text] [Related]
9. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002.
Wang H; Chen M;
Diagn Microbiol Infect Dis; 2005 Mar; 51(3):201-8. PubMed ID: 15766607
[TBL] [Abstract][Full Text] [Related]
11. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
Streit JM; Jones RN; Sader HS; Fritsche TR
Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
[TBL] [Abstract][Full Text] [Related]
12. Horizontal gene transfer-emerging multidrug resistance in hospital bacteria.
Dzidic S; Bedeković V
Acta Pharmacol Sin; 2003 Jun; 24(6):519-26. PubMed ID: 12791177
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
[TBL] [Abstract][Full Text] [Related]
14. Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli.
Toltzis P; Dul M; O'Riordan MA; Salvator A; Rosolowski B; Toltzis H; Blumer JL
Pediatr Infect Dis J; 2003 Feb; 22(2):109-14. PubMed ID: 12586972
[TBL] [Abstract][Full Text] [Related]
15. The current state of multidrug-resistant gram-negative bacilli in North America.
Nicasio AM; Kuti JL; Nicolau DP
Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
[TBL] [Abstract][Full Text] [Related]
16. Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania.
Ndugulile F; Jureen R; Harthug S; Urassa W; Langeland N
BMC Infect Dis; 2005 Oct; 5():86. PubMed ID: 16225701
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.
Wroblewska MM; Rudnicka J; Marchel H; Luczak M
Int J Antimicrob Agents; 2006 Apr; 27(4):285-9. PubMed ID: 16545949
[TBL] [Abstract][Full Text] [Related]
18. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
[TBL] [Abstract][Full Text] [Related]
19. [The drug resistance of pathogenic bacteria of nosocomial infections in surgical intensive care unit].
Chen J; Li LF; Guan XD; Chen DM; Chen MY; Ouyang B; Huang SW; Wu JF
Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1189-92. PubMed ID: 17147864
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]